DRIO DarioHealth Corp

Price (delayed)

$1.225

Market cap

$36.66M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.68

Enterprise value

$32.72M

DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software ...

Highlights
DRIO's equity is up by 34% since the previous quarter and by 8% year-on-year
DRIO's EPS is up by 29% year-on-year and by 13% since the previous quarter
DarioHealth's gross profit has decreased by 41% YoY and by 12% from the previous quarter
The revenue has declined by 29% year-on-year and by 6% since the previous quarter

Key stats

What are the main financial stats of DRIO
Market
Shares outstanding
29.92M
Market cap
$36.66M
Enterprise value
$32.72M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.46
Price to sales (P/S)
2.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.72
Earnings
Revenue
$19.04M
EBIT
-$55.71M
EBITDA
-$50.61M
Free cash flow
-$39.3M
Per share
EPS
-$1.68
Free cash flow per share
-$1.14
Book value per share
$2.65
Revenue per share
$0.55
TBVPS
$1.62
Balance sheet
Total assets
$136.96M
Total liabilities
$58.93M
Debt
$30.44M
Equity
$78.03M
Working capital
$34.71M
Liquidity
Debt to equity
0.39
Current ratio
2.95
Quick ratio
2.67
Net debt/EBITDA
0.08
Margins
EBITDA margin
-265.7%
Gross margin
27.6%
Net margin
-282.4%
Operating margin
-323.7%
Efficiency
Return on assets
-52.4%
Return on equity
-84.8%
Return on invested capital
-162.3%
Return on capital employed
-46.7%
Return on sales
-292.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DRIO stock price

How has the DarioHealth stock price performed over time
Intraday
1.24%
1 week
-9.26%
1 month
1.24%
1 year
-71.04%
YTD
-28.78%
QTD
2.94%

Financial performance

How have DarioHealth's revenue and profit performed over time
Revenue
$19.04M
Gross profit
$5.25M
Operating income
-$61.64M
Net income
-$53.78M
Gross margin
27.6%
Net margin
-282.4%
DRIO's operating margin has dropped by 62% year-on-year and by 17% since the previous quarter
DarioHealth's gross profit has decreased by 41% YoY and by 12% from the previous quarter
The revenue has declined by 29% year-on-year and by 6% since the previous quarter
The net margin has contracted by 27% YoY but it has grown by 3.3% from the previous quarter

Growth

What is DarioHealth's growth rate over time

Valuation

What is DarioHealth stock price valuation
P/E
N/A
P/B
0.46
P/S
2.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.72
DRIO's EPS is up by 29% year-on-year and by 13% since the previous quarter
The P/B is 76% lower than the 5-year quarterly average of 1.9 and 54% lower than the last 4 quarters average of 1.0
DRIO's equity is up by 34% since the previous quarter and by 8% year-on-year
DRIO's P/S is 73% below its 5-year quarterly average of 8.0 and 36% below its last 4 quarters average of 3.4
The revenue has declined by 29% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is DarioHealth business performance
DRIO's ROS is down by 32% year-on-year
The ROIC has grown by 24% YoY and by 11% from the previous quarter
DarioHealth's return on equity has decreased by 20% YoY but it has increased by 8% QoQ
DRIO's ROA is up by 12% QoQ but it is down by 7% YoY

Dividends

What is DRIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DRIO.

Financial health

How did DarioHealth financials performed over time
The total assets is 132% greater than the total liabilities
DRIO's total liabilities has surged by 64% year-on-year and by 54% since the previous quarter
The total assets has grown by 42% since the previous quarter and by 27% year-on-year
The debt is 61% less than the equity
DRIO's equity is up by 34% since the previous quarter and by 8% year-on-year
The company's debt to equity fell by 24% QoQ but it rose by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.